Vulnerability in Dexma Dexgate
CVE-2023-41088
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.3 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N.
EPSS exploit prediction
EPSS: 0.003 (19.3th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 19th percentile — 19.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.002 · newest: 0.003 · change: +0.000
Affected products
- Dexma Dexgate — versions 20130114, version 20130114
Weakness classification (CWE)
References
- www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 (US Government Resource, Third Party Advisory)
Frequently asked questions
- What is CVE-2023-41088?
- CVE-2023-41088 is a medium-severity vulnerability in Dexma Dexgate, classified under Cleartext Transmission of Sensitive Information. CVSS score: 6.3/10. Published 2023-10-19.
- How severe is CVE-2023-41088?
- Medium severity. CVSS v3 base score is 6.3 out of 10.